APA (7th ed.) Citation

Demacq, C., Vasconcellos, V. B., Marcaccini, A. M., Gerlach, R. F., Machado, A. A., & Tanus-Santos, J. E. (2009). A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients. The pharmacogenomics journal, 9(4), 265-273. https://doi.org/10.1038/tpj.2009.13

Chicago Style (17th ed.) Citation

Demacq, C., V B. Vasconcellos, A M. Marcaccini, R F. Gerlach, A A. Machado, and J E. Tanus-Santos. "A Genetic Polymorphism of Matrix Metalloproteinase 9 (MMP-9) Affects the Changes in Circulating MMP-9 Levels Induced by Highly Active Antiretroviral Therapy in HIV Patients." The Pharmacogenomics Journal 9, no. 4 (2009): 265-273. https://doi.org/10.1038/tpj.2009.13.

MLA (9th ed.) Citation

Demacq, C., et al. "A Genetic Polymorphism of Matrix Metalloproteinase 9 (MMP-9) Affects the Changes in Circulating MMP-9 Levels Induced by Highly Active Antiretroviral Therapy in HIV Patients." The Pharmacogenomics Journal, vol. 9, no. 4, 2009, pp. 265-273, https://doi.org/10.1038/tpj.2009.13.